557 related articles for article (PubMed ID: 27753791)
21.
Ma Q; Wang K; Yang Q; Ping S; Zhao W; Shou Q; Zhou W; Chen M
Mediators Inflamm; 2016; 2016():7934049. PubMed ID: 27890971
[No Abstract] [Full Text] [Related]
22. Total flavonoids of Inula japonica alleviated the inflammatory response and oxidative stress in LPS-induced acute lung injury via inhibiting the sEH activity: Insights from lipid metabolomics.
Zhang J; Zhang M; Zhang WH; Zhu QM; Huo XK; Sun CP; Ma XC; Xiao HT
Phytomedicine; 2022 Dec; 107():154380. PubMed ID: 36150346
[TBL] [Abstract][Full Text] [Related]
23. Angelicin regulates LPS-induced inflammation via inhibiting MAPK/NF-κB pathways.
Liu F; Sun GQ; Gao HY; Li RS; Soromou LW; Chen N; Deng YH; Feng HH
J Surg Res; 2013 Nov; 185(1):300-9. PubMed ID: 23816246
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of PKR ameliorates lipopolysaccharide-induced acute lung injury by suppressing NF-κB pathway in mice.
Li Y; Xiao J; Tan Y; Wang J; Zhang Y; Deng X; Luo Y
Immunopharmacol Immunotoxicol; 2017 Aug; 39(4):165-172. PubMed ID: 28511573
[TBL] [Abstract][Full Text] [Related]
25. Nano-chemically Modified Tetracycline-3 (nCMT-3) Attenuates Acute Lung Injury via Blocking sTREM-1 Release and NLRP3 Inflammasome Activation.
Meng Q; Wang X; Guo D; Shi C; Gu R; Ma J; Nieman G; Kollisch-Singule M; Luo J; Cooney RN
Shock; 2022 May; 57(5):749-758. PubMed ID: 35583915
[TBL] [Abstract][Full Text] [Related]
26. Anti-inflammatory effects of novel curcumin analogs in experimental acute lung injury.
Zhang Y; Liang D; Dong L; Ge X; Xu F; Chen W; Dai Y; Li H; Zou P; Yang S; Liang G
Respir Res; 2015 Mar; 16(1):43. PubMed ID: 25889862
[TBL] [Abstract][Full Text] [Related]
27. Protectin DX Exhibits Protective Effects in Mouse Model of Lipopolysaccharide-Induced Acute Lung Injury.
Tan W; Chen L; Wang YX; Hu LS; Xiong W; Shang Y; Yao SL
Chin Med J (Engl); 2018 May; 131(10):1167-1173. PubMed ID: 29553051
[TBL] [Abstract][Full Text] [Related]
28. Soluble epoxide hydrolase inhibitor trifluoromethoxyphenyl-3-(1-propionylpiperidin-4-yl)urea prevents hyperalgesia through regulating NLRC4 inflammasome-related pro-inflammatory and anti-inflammatory signaling pathways in the lipopolysaccharide-induced pain mouse model.
Cagli A; Senol SP; Temiz-Resitoglu M; Guden DS; Sari AN; Sahan-Firat S; Tunctan B
Drug Dev Res; 2021 Sep; 82(6):815-825. PubMed ID: 33559150
[TBL] [Abstract][Full Text] [Related]
29. PIM1 inhibitor SMI-4a attenuated lipopolysaccharide-induced acute lung injury through suppressing macrophage inflammatory responses via modulating p65 phosphorylation.
Wang J; Cao Y; Liu Y; Zhang X; Ji F; Li J; Zou Y
Int Immunopharmacol; 2019 Aug; 73():568-574. PubMed ID: 31203114
[TBL] [Abstract][Full Text] [Related]
30. Saikosaponin a Ameliorates LPS-Induced Acute Lung Injury in Mice.
Du ZA; Sun MN; Hu ZS
Inflammation; 2018 Feb; 41(1):193-198. PubMed ID: 28986747
[TBL] [Abstract][Full Text] [Related]
31. Necrostatin-1 attenuates lipopolysaccharide-induced acute lung injury in mice.
Guan E; Wang Y; Wang C; Zhang R; Zhao Y; Hong J
Exp Lung Res; 2017; 43(9-10):378-387. PubMed ID: 29199874
[TBL] [Abstract][Full Text] [Related]
32. Rhesus θ-Defensin-1 Attenuates Endotoxin-induced Acute Lung Injury by Inhibiting Proinflammatory Cytokines and Neutrophil Recruitment.
Jayne JG; Bensman TJ; Schaal JB; Park AYJ; Kimura E; Tran D; Selsted ME; Beringer PM
Am J Respir Cell Mol Biol; 2018 Mar; 58(3):310-319. PubMed ID: 28954201
[TBL] [Abstract][Full Text] [Related]
33. Ouabain Protects Mice Against Lipopolysaccharide-Induced Acute Lung Injury.
Wang C; Meng Y; Wang Y; Jiang Z; Xu M; Bo L; Deng X
Med Sci Monit; 2018 Jun; 24():4455-4464. PubMed ID: 29953424
[TBL] [Abstract][Full Text] [Related]
34. 3,4,5-Trihydroxycinnamic acid attenuates lipopolysaccharide (LPS)-induced acute lung injury via downregulating inflammatory molecules and upregulating HO-1/AMPK activation.
Lee JW; Chun W; Kwon OK; Park HA; Lim Y; Lee JH; Kim DY; Kim JH; Lee HK; Ryu HW; Oh SR; Ahn KS
Int Immunopharmacol; 2018 Nov; 64():123-130. PubMed ID: 30173052
[TBL] [Abstract][Full Text] [Related]
35. Ulinastatin inhibits the inflammation of LPS-induced acute lung injury in mice via regulation of AMPK/NF-κB pathway.
Li W; Qiu X; Jiang H; Zhi Y; Fu J; Liu J
Int Immunopharmacol; 2015 Dec; 29(2):560-567. PubMed ID: 26481965
[TBL] [Abstract][Full Text] [Related]
36. Euphorbia factor L2 alleviates lipopolysaccharide-induced acute lung injury and inflammation in mice through the suppression of NF-κB activation.
Zhang Q; Zhu S; Cheng X; Lu C; Tao W; Zhang Y; William BC; Cao X; Yi S; Liu Y; Zhao Y; Luo Y
Biochem Pharmacol; 2018 Sep; 155():444-454. PubMed ID: 30055150
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of soluble epoxide hydrolase alleviates insulin resistance and hypertension via downregulation of SGLT2 in the mouse kidney.
Luo J; Hu S; Fu M; Luo L; Li Y; Li W; Cai Y; Dong R; Yang Y; Tu L; Xu X
J Biol Chem; 2021; 296():100667. PubMed ID: 33864813
[TBL] [Abstract][Full Text] [Related]
38. Asiaticoside attenuates lipopolysaccharide-induced acute lung injury via down-regulation of NF-κB signaling pathway.
Qiu J; Yu L; Zhang X; Wu Q; Wang D; Wang X; Xia C; Feng H
Int Immunopharmacol; 2015 May; 26(1):181-7. PubMed ID: 25835778
[TBL] [Abstract][Full Text] [Related]
39. Plantamajoside ameliorates lipopolysaccharide-induced acute lung injury via suppressing NF-κB and MAPK activation.
Wu H; Zhao G; Jiang K; Chen X; Zhu Z; Qiu C; Li C; Deng G
Int Immunopharmacol; 2016 Jun; 35():315-322. PubMed ID: 27089391
[TBL] [Abstract][Full Text] [Related]
40. Attenuation of cisplatin-induced renal injury by inhibition of soluble epoxide hydrolase involves nuclear factor κB signaling.
Liu Y; Webb HK; Fukushima H; Micheli J; Markova S; Olson JL; Kroetz DL
J Pharmacol Exp Ther; 2012 Jun; 341(3):725-34. PubMed ID: 22414856
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
